ACAD
30.94
-0.14
-0.45%
AEMD
1.51
-0.02
-1.31%
APRI
1.48
-0.01
-0.67%
ARNA
20.26
-0.27
-1.32%
ATEC
1.94
+0.02
+1.04%
CNAT
5.15
+0.14
+2.79%
CRXM
0.17
+0.01
+4.20%
CYTX
0.311
-0.011
-3.5039%
DXCM
73.06
-0.14
-0.19%
GNMK
9.54
-0.06
-0.63%
HALO
11.9
+0.02
+0.17%
ILMN
190.68
+1.36
+0.72%
INNV
0.108
+0.008
+7.5000%
INO
5.46
+0.01
+0.18%
ISCO
1.25
-0.07
-5.30%
ISIS
57.56
0.00
0.00%
LGND
126.55
+0.29
+0.23%
LPTN
2.93
-2.93
-100.00%
MBVX
0.51
+0.01
+2.00%
MEIP
2.6
-0.08
-2.99%
MNOV
4.97
0.00
0.00%
MRTX
5.45
-0.15
-2.68%
MSTX
0.13
-0.01
-5.28%
NBIX
52.13
-0.02
-0.04%
NUVA
64.48
+0.42
+0.66%
ONCS
0.89
-0.03
-3.2500%
ONVO
1.81
-0.04
-2.16%
OREX
2.39
-0.03
-1.24%
OTIC
20.25
+1.5
+8.00%
QDEL
32.77
+0.16
+0.49%
RCPT
231.96
0.00
0.00%
RGLS
0.846
+0.02
+2.4573%
RMD
73.44
+0.37
+0.51%
SCIE
0
0.00
-33.3333%
SPHS
1.82
-0.08
-4.21%
SRNE
1.7
-0.05
-2.86%
TROV
0.82
-0.01
-1.17%
VICL
2.34
-0.09
-3.70%
VOLC
18
0.00
0.00%
ZGNX
12.3
+0.05
+0.41%
ACAD
30.94
-0.14
-0.45%
AEMD
1.51
-0.02
-1.31%
APRI
1.48
-0.01
-0.67%
ARNA
20.26
-0.27
-1.32%
ATEC
1.94
+0.02
+1.04%
CNAT
5.15
+0.14
+2.79%
CRXM
0.17
+0.01
+4.20%
CYTX
0.311
-0.011
-3.5039%
DXCM
73.06
-0.14
-0.19%
GNMK
9.54
-0.06
-0.63%
HALO
11.9
+0.02
+0.17%
ILMN
190.68
+1.36
+0.72%
INNV
0.108
+0.008
+7.5000%
INO
5.46
+0.01
+0.18%
ISCO
1.25
-0.07
-5.30%
ISIS
57.56
0.00
0.00%
LGND
126.55
+0.29
+0.23%
LPTN
2.93
-2.93
-100.00%
MBVX
0.51
+0.01
+2.00%
MEIP
2.6
-0.08
-2.99%
MNOV
4.97
0.00
0.00%
MRTX
5.45
-0.15
-2.68%
MSTX
0.13
-0.01
-5.28%
NBIX
52.13
-0.02
-0.04%
NUVA
64.48
+0.42
+0.66%
ONCS
0.89
-0.03
-3.2500%
ONVO
1.81
-0.04
-2.16%
OREX
2.39
-0.03
-1.24%
OTIC
20.25
+1.5
+8.00%
QDEL
32.77
+0.16
+0.49%
RCPT
231.96
0.00
0.00%
RGLS
0.846
+0.02
+2.4573%
RMD
73.44
+0.37
+0.51%
SCIE
0
0.00
-33.3333%
SPHS
1.82
-0.08
-4.21%
SRNE
1.7
-0.05
-2.86%
TROV
0.82
-0.01
-1.17%
VICL
2.34
-0.09
-3.70%
VOLC
18
0.00
0.00%
ZGNX
12.3
+0.05
+0.41%
Home » Archive by Category

Xconomy

Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More

August 4, 2017 – 3:20 am

Gene editing took an important step this week when a group of U.S. researchers used CRISPR-Cas9 technology to correct a genetic error in dozens of human embryos without complications. It’s a…

[[Click headline to continue reading.]]

Cibus Readies Enhanced Crops for Push into Canada, and Beyond

August 2, 2017 – 8:40 pm

After raising $57 million in a Series B round of venture funding, the San Diego agricultural biotech Cibus Global is laying the groundwork to introduce its first commercial product in Canada. Cibus…

[[Click headline to continue reading.]]

San Diego’s Amplyx Raises $67M to Advance New Anti-Fungal Drug

August 1, 2017 – 10:01 pm

After completing an early stage evaluation of its broad-spectrum anti-fungal drug, San Diego’s Amplyx Pharmaceuticals said Wednesday it has raised $67 million in a Series C financing round led by a…

[[Click headline to continue reading.]]

Bio Roundup: GOP Drama, Immunotherapy Setbacks, Pharma Revamps

July 28, 2017 – 3:23 am

Two failed cancer studies this week provided a fresh reminder how little researchers and clinicians understand about immunotherapy’s vagaries: why it works for some people and not for others….

[[Click headline to continue reading.]]

Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails

July 27, 2017 – 4:27 am

Despite all the great progress made harnessing the immune system to fight cancer, there is still much work to be done to maximize its potential. The latest evidence: disappointing results today from…

[[Click headline to continue reading.]]

Illumina Accelerator Sees ‘Huge Impact in Genomics’ in New Startups

July 26, 2017 – 2:00 am

Genomics startups are increasing in number and quality, so much so that three-year-old Illumina Accelerator has expanded with its latest class to accommodate five of them. Xconomy got an early look…

[[Click headline to continue reading.]]

Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs

July 24, 2017 – 8:59 pm

San Diego’s Effector Therapeutics, a five-year-old cancer drug developer, has raised $38.6 million in new venture capital funding. The Series C financing, led by Pfizer Venture Investments, brings…

[[Click headline to continue reading.]]

With Helix’s Help, Lose It Adds Genetic Insights to Weight Loss App

July 24, 2017 – 3:30 am

Does your genetic code contain information that can help you lose weight? It’s a serious question in science, and in business. Now, the makers of Lose It aim to find out. The nine-year-old mobile…

[[Click headline to continue reading.]]

Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More

July 21, 2017 – 2:45 am

The attempt to repeal and replace the Affordable Care Act took a major hit this week from Senate GOP holdouts who said the Better Care Reconciliation Act either tore down Medicaid too much or left…

[[Click headline to continue reading.]]

A.I. Prizes, Coming to Healthcare, Hit $1M Mark in Cancer Contests

July 20, 2017 – 4:58 am

This story is part of an Xconomy series on artificial intelligence in healthcare. Some of the other stories cover a genomics hackathon, A.I. and radiology, and the impact on doctors and patients. In…

[[Click headline to continue reading.]]